Effect of Fenofibrate on Sleep Apnea Syndrome

NCT00816829 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped The study was prematurely terminated because of slow recruitment

Conditions

Dyslipidemia
Sleep Apnea Syndrome
Overweight
Obesity

Interventions

DRUG: Placebo
DRUG: Fenofibrate

Sponsor

Solvay Pharmaceuticals